Navigation Links
Opiates Better Than Sedatives For Treating Newborns In Withdrawal

For years, sedatives have been the gold standard for treating newborns suffering from opiate withdrawal. However, new research suggests that opiates themselves are superior to sedatives for treating infants born to women who used heroin or methadone while pregnant.

Opiates appear to better "ameliorate the withdrawal, facilitate feeding and potentially reduce the likelihood of seizures," according to two new systematic reviews done by David Osborn, a neonatologist at the Royal Prince Alfred Hospital in Sydney, Australia, and colleagues.

The researchers also found that infants treated with opiates regained birth weight more quickly than those who only received supportive care.

According to their analysis, the use of opiates instead of sedatives or supportive care alone shortens the duration of supportive care by an average of four days. When compared to diazepam (Valium), opiates reduce the incidence of treatment failure.

However, infants treated with opiates had longer hospital stays than those treated with phenobarbitone, the sedative most often used in these cases. When sedatives only were compared, phenobarbitone was more likely than diazepam to reduce treatment failure.

The reviews appear in the July issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.

The reviews included 13 studies with a total of 890 infants of mothers who had used opiates with or without other drugs (including antidepressants, sleep aids and marijuana) during pregnancy. Researchers say two of the studies may have included identical patients.

Newborns suffering from neonatal abstinence syndrome (NAS) exhibit seizures, poor feeding, diarrhea and vomiting that lead to excessive weight loss and dehydr
'"/>

Source:Center for the Advancement of Health


Page: 1 2

Related biology news :

1. Institute for Systems Biology Symposium Addresses Need for Better Computational Tools
2. Protein Discovery Could Unlock The Secret To Better TB Treatment
3. Computational Tool Predicts How Drugs Work In Cells, Advancing Efforts To Design Better Medicines
4. Newly Discovered Role for Heart Response Enzyme May Yield Better Heart Failure Therapy
5. Better beetle sought for salt cedar control
6. Better sludge through metagenomics
7. Better assessment of transfusions could save blood
8. Better health twice as likely for nonsmokers who live and work with smoking restrictions
9. Potential Drug Target For Treating Cocaine Abuse Found
10. NCI Researchers Confirm the Effectiveness of Immunotherapy Approach to Treating Melanoma
11. Treating populations infected with HIV and latent TB could speed the emergence of drug-resistant TB

Post Your Comments:
(Date:11/5/2009)...ty have developed synthetic molecules capable of e...-infected cells, as well as to prostate cancer cel...al of the American Chemical Society , could lead t... , The molecules called "antibody-recruiting m...iting molecule targeting prostate cancer" (ARM-P) ...
(Date:11/4/2009)...g Beach and Riverside are responsible for a signif...and the true impact of air pollution and ship emis...d, according to researchers at the University of S...pears in an online edition of the American Journa...f all childhood asthma cases in Long Beach and six...
(Date:11/4/2009)...eived more than $10 million in research grants fro...mulus program, bringing thetotal amount of stimulu...n. Thirty-three projects achieved stimulus fundin... , "The university has thoughtfully undertaken a... excellence to federal agency priorities. Through...
Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2USC study finds big air pollution impacts on local communities 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Zimmer Holdings to Present at Upcoming Investor Conferences 55934 1DIA Conference to Explore The Science and Scope of Personalized Medicine 55930 1DIA Conference to Explore The Science and Scope of Personalized Medicine 55930 2U S Labor Department announces dates for 4th annual Drug Free Work Week 55926 1U S Labor Department announces dates for 4th annual Drug Free Work Week 55926 2
...nced Identification Systems/Commerc... 28 /PRNewswire-FirstCall/-- Atmel (Nasdaq:,ATML),...ns, announced today,that Kerry Maletsky, Business ...nt "Secure Biometric Co-processor: Solving the Net...on Systems/Commercial Biometrics,Conference in Was...
...MEA spurs IdentiPHI,s company ...tiPHI, Inc., an innovative,leader in enterprise se...sion with the opening of an office in Paris to add...identity and authentication (access,management) pr...ope will enable us to more closely serve our,growi...
...cans are an increasingly used X-ray-based tool for...r organ or tissue. The value of CT scanning to dia...undisputed. But are these scans being used too fre... health consequences of having too many CT scans o... 2007 article in The New England Journal of Medici...
Other Biology News:Atmel's Biometric Co-processor Solution Featured at AIS/CBX 2IdentiPHI Opens Paris Office to Boost European Sales and Support 2Columbia researchers: Growth of CT scan use may lead to significant public health problem 2Columbia researchers: Growth of CT scan use may lead to significant public health problem 3
(Date:11/5/2009)...Nov. 5 Transgenomic, Inc...cial results for the quarter ended September 30, 2... in the tables that follow. ,, Third Quarter 2...,000 or $0.01 per share for the third quarter of 2... per share for the third quarter of 2008. ,, N...
(Date:11/5/2009)...f., Nov. 5 WaferGen Bios... developer of state-of-the-art genetic analysis sy...D. has joined the company,s Scientific Advisory Bo... commercializing novel molecular diagnostics for c... development of computational biology systems for ...
(Date:11/5/2009)... Brooke Sanders brings a new look to Pro Rep...ovember 5, 2009 -- Professional Reprographics, Ora...ompany is pleased to present Brooke Sanders to the...cs/PR specialist. The addition of Brooke to the co...ithin Professional Reprographics., , ,Brooke bring...
(Date:11/4/2009)...KVILLE, Md., Nov. 4 Zyngenia, Inc.... on next-generation antibody drug development, tod...ries A funding from New Enterprise Associates (NEA...s. The capital will be used to create novel, multi... or more biological targets with a single agent. T...
Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4Zyngenia, Inc. Raises $10 Million in Series A Funding 2Zyngenia, Inc. Raises $10 Million in Series A Funding 3Zyngenia, Inc. Raises $10 Million in Series A Funding 4
...lix BioPharma Corp. (TSX, FSE: "HBP") today announ...scal 2009, ended January 31, 2009. , , RECENT H...-F registration statement with the U.S. Securities... March 12, 2009 , , , , , , Helix...European Phase II pharmacokinetic study in human s...
... Protocol Driven Healthcare , Inc. (PDHI) now of...(HRA), the ConXus(R) Profile. The shorter format f...racy and reduces processing costs of paper assessm..., longer adult HRA, but joins PDHI,s suite of Con...students, children, and Spanish-speaking adults. ...
...nership Will Increase Productivity to Meet Growing... Indonesia (PRWEB) March 16, 2009 -- DuPont and ...oday announced an agreement that grants DuPont bus...ialize ICRR rice hybrids in Asia. , , , , ,Rice is... of the world,s population. The growing populatio...
Other Biology Technology:Helix BioPharma Announces Q2 2009 Financial Results 2Helix BioPharma Announces Q2 2009 Financial Results 3Helix BioPharma Announces Q2 2009 Financial Results 4Helix BioPharma Announces Q2 2009 Financial Results 5Helix BioPharma Announces Q2 2009 Financial Results 6Helix BioPharma Announces Q2 2009 Financial Results 7Helix BioPharma Announces Q2 2009 Financial Results 8Helix BioPharma Announces Q2 2009 Financial Results 9Helix BioPharma Announces Q2 2009 Financial Results 10Helix BioPharma Announces Q2 2009 Financial Results 11Helix BioPharma Announces Q2 2009 Financial Results 12PDHI Launches Short Form of Its ConXus Profile Health Assessment 2DuPont Partners with Indonesian Center for Rice Research to Advance Hybrid Rice 2DuPont Partners with Indonesian Center for Rice Research to Advance Hybrid Rice 3
Mouse Anti-IFN-alpha2 Monoclonal Antibody, Fluorescein isothiocyanate (FITC) Conjugated, Clone 225.C from eBioscience
Mouse Anti-alpha Sodium Potassium ATPase Monoclonal Antibody, Unconjugated, Clone M7-PB-E9 from Abcam
Rabbit Anti-Human SP2 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Rabbit Anti-Asparagine synthetase Monoclonal Antibody, Unconjugated, Clone EP282Y from Abcam
Biology Products: